Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06041594 · ClinicalTrials.gov registry record · NA

Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)

A NA study of Pulmonary Embolism, sponsored by Innova Vascular.

Recruiting
Registry status
NA
Development phase
107
Enrollment target
14
Study locations

NCT06041594 is a NA study of Pulmonary Embolism that is actively recruiting participants, run by Innova Vascular. The registered enrollment target is 107 participants, below the 3,056-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (96% lower). The trial reports 14 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06041594, a NA study of Pulmonary Embolism, is actively recruiting participants, sponsored by Innova Vascular.

RECRUITING
Registry status
NA
Development phase
107 participants
Enrollment target
14
Study locations

Study Summary

This is a prospective, multi-center, pivotal study to demonstrate the safety and effectiveness of the Laguna Thrombectomy System for the treatment of pulmonary embolism. The Laguna Thrombectomy System is an investigational device which consists of the Laguna Clot Retriever™ System and the Malibu Aspiration Catheter™ System. These devices are manufactured by Innova Vascular, Inc.

Conditions Studied

Pulmonary Embolism

Interventions

  • DEVICE Laguna Thrombectomy System

Study Locations (14)

California

  • University of California Irvine - Irvine
  • Memorial Care Long Beach Medical Center - Long Beach
  • Mission Hospital Regional Medical Center - Mission Viejo
  • St. Joseph Hospital of Orange - Orange

Other

  • Ankara Bilkent City Hospital - Ankara
  • Hacettepe University Hospital - Ankara
  • Sancaktepe Sehit Prof. Dr. Ilhan Varan Training and Research Hospital - Istanbul
  • Dokuz Eylul University Research and Application Hospital - Izmir

Florida

  • Manatee Memorial Hospital - Bradenton
  • AdventHealth Tampa - Tampa

District of Columbia

  • George Washington University - Washington D.C.

Illinois

  • Rush University Medical Center - Chicago

New York

  • Albany Medical Center - Albany

North Carolina

  • University of North Carolina at Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 107 participants
Start Date 2024-08-19
Est. Completion 2026-04
Phase NA

Sponsor

Innova Vascular

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06041594

The ClinicalTrials.gov registry entry for NCT06041594 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,056-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (96% lower). The listed sponsor is Innova Vascular, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pulmonary Embolism appearing as the primary indexed condition, and to 1 intervention - of which Laguna Thrombectomy System is the first listed.

NCT06041594 reports 14 study locations spanning 7 distinct geographic areas - top geographies include California, Other, Florida.

Frequently Asked Questions

What is clinical trial NCT06041594 about?

NCT06041594 is a clinical study titled "Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)". This is a prospective, multi-center, pivotal study to demonstrate the safety and effectiveness of the Laguna Thrombectomy System for the treatment of pulmonary embolism. The Laguna Thrombectomy System is an investigational device which consists of the Laguna Clot Retriever™ System and the Malibu Asp...

What is the current status of trial NCT06041594?

This trial is currently recruiting. It is a NA study. The enrollment target is 107 participants. The study started on 2024-08-19. Estimated completion is 2026-04.

What conditions does trial NCT06041594 study?

This clinical trial studies the following conditions: Pulmonary Embolism.

What interventions are being tested in trial NCT06041594?

The interventions under investigation include: Laguna Thrombectomy System (DEVICE).

Who is sponsoring clinical trial NCT06041594?

This trial is sponsored by Innova Vascular, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06041594 being conducted?

This trial has 14 study locations across California, District of Columbia, Florida, Illinois, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pulmonary Embolism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Pulmonary Embolism

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.